Integra LifeSciences IART Total Liabilities & Equity
Total Liabilities & Equity at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.
The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Integra LifeSciences's total liabilities & equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Integra LifeSciences's total liabilities & equity?
- Integra LifeSciences (IART) reported total liabilities & equity of $3.58B in Q1 2026.
- How has Integra LifeSciences's total liabilities & equity changed year-over-year?
- Integra LifeSciences's total liabilities & equity decreased by 11.7% year-over-year, from $4.05B to $3.58B.
- What is the long-term trend for Integra LifeSciences's total liabilities & equity?
- Over 5 years (2020 to 2025), Integra LifeSciences's total liabilities & equity has grown at a -0.1% compound annual growth rate (CAGR), from $3.62B to $3.6B.
- What does total liabilities & equity mean?
- Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.